
Group Structure
View All
Industry
Other human health activities
Registered Address
keech hospice care, great bramingham lane, luton, LU3 3NT
Website
http://keech.org.ukPomanda estimates the enterprise value of KEECH HOSPICE at £9.9m based on a Turnover of £15.4m and 0.64x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of KEECH HOSPICE at £5.4m based on an EBITDA of £1.1m and a 4.89x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of KEECH HOSPICE at £47.2m based on Net Assets of £21.1m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Keech Hospice is a live company located in luton, LU3 3NT with a Companies House number of 02904446. It operates in the other human health activities sector, SIC Code 86900. Founded in March 1994, it's largest shareholder is unknown. Keech Hospice is a mature, mid sized company, Pomanda has estimated its turnover at £15.4m with healthy growth in recent years.
Pomanda's financial health check has awarded Keech Hospice a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
3 Weak
Size
annual sales of £15.4m, make it larger than the average company (£731.1k)
£15.4m - Keech Hospice
£731.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (7.2%)
7% - Keech Hospice
7.2% - Industry AVG
Production
with a gross margin of 38.4%, this company has a comparable cost of product (38.4%)
38.4% - Keech Hospice
38.4% - Industry AVG
Profitability
an operating margin of 3.9% make it less profitable than the average company (5.2%)
3.9% - Keech Hospice
5.2% - Industry AVG
Employees
with 266 employees, this is above the industry average (18)
266 - Keech Hospice
18 - Industry AVG
Pay Structure
on an average salary of £35.5k, the company has a higher pay structure (£26.5k)
£35.5k - Keech Hospice
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £57.9k, this is more efficient (£45.8k)
£57.9k - Keech Hospice
£45.8k - Industry AVG
Debtor Days
it gets paid by customers after 1 days, this is earlier than average (20 days)
1 days - Keech Hospice
20 days - Industry AVG
Creditor Days
its suppliers are paid after 14 days, this is quicker than average (18 days)
14 days - Keech Hospice
18 days - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (13 days)
0 days - Keech Hospice
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 320 weeks, this is more cash available to meet short term requirements (124 weeks)
320 weeks - Keech Hospice
124 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 4.8%, this is a lower level of debt than the average (22.7%)
4.8% - Keech Hospice
22.7% - Industry AVG
Keech Hospice's latest turnover from March 2024 is £15.4 million and the company has net assets of £21.1 million. According to their latest financial statements, Keech Hospice has 266 employees and maintains cash reserves of £6.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 15,402,000 | 13,395,000 | 15,879,000 | 12,629,000 | 10,973,000 | 10,150,000 | 10,657,000 | 10,051,000 | 9,914,000 | 10,198,000 | 10,484,000 | 8,454,000 | 7,755,000 | 7,517,000 | 6,982,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | 771,000 | 1,220,000 | 4,915,000 | 1,950,000 | 238,000 | -617,000 | 331,000 | 107,000 | 327,000 | 1,028,000 | 1,425,000 | 313,000 | 20,000 | 328,000 | -433,000 |
Tax | |||||||||||||||
Profit After Tax | 771,000 | 1,220,000 | 4,915,000 | 1,950,000 | 238,000 | -617,000 | 331,000 | 107,000 | 327,000 | 1,028,000 | 1,425,000 | 313,000 | 20,000 | 328,000 | -433,000 |
Dividends Paid | |||||||||||||||
Retained Profit | 771,000 | 1,220,000 | 4,915,000 | 1,950,000 | 238,000 | -617,000 | 331,000 | 107,000 | 327,000 | 1,028,000 | 1,425,000 | 313,000 | 20,000 | 328,000 | -433,000 |
Employee Costs | 9,430,000 | 7,954,000 | 7,153,000 | 7,079,000 | 7,220,000 | 7,050,000 | 6,799,000 | 6,356,000 | 6,157,000 | 5,921,000 | 5,681,000 | 5,249,000 | 4,902,000 | 4,613,000 | 4,636,000 |
Number Of Employees | 266 | 242 | 273 | 284 | 297 | 290 | 286 | 264 | 269 | 266 | 249 | 224 | 210 | 199 | 177 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 7,957,000 | 7,707,000 | 7,883,000 | 8,078,000 | 8,417,000 | 8,141,000 | 8,311,000 | 8,437,000 | 8,614,000 | 8,702,000 | 8,005,000 | 6,984,000 | 7,180,000 | 7,230,000 | 7,272,000 |
Intangible Assets | |||||||||||||||
Investments & Other | 5,553,000 | 1,986,000 | 108,000 | 154,000 | 77,000 | 99,000 | 101,000 | 96,000 | |||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 13,510,000 | 9,693,000 | 7,883,000 | 8,078,000 | 8,417,000 | 8,141,000 | 8,311,000 | 8,437,000 | 8,614,000 | 8,810,000 | 8,159,000 | 7,061,000 | 7,279,000 | 7,331,000 | 7,368,000 |
Stock & work in progress | 18,000 | 15,000 | 13,000 | 21,000 | 16,000 | 13,000 | 12,000 | 5,000 | 7,000 | 4,000 | 4,000 | 3,000 | 9,000 | 2,000 | 3,000 |
Trade Debtors | 62,000 | 413,000 | 163,000 | 275,000 | 314,000 | 27,000 | 158,000 | 108,000 | 175,000 | 109,000 | 101,000 | 123,000 | 52,000 | 40,000 | 127,000 |
Group Debtors | |||||||||||||||
Misc Debtors | 1,549,000 | 1,002,000 | 4,076,000 | 2,243,000 | 1,980,000 | 1,535,000 | 1,291,000 | 1,058,000 | 1,025,000 | 711,000 | 731,000 | 336,000 | 291,000 | 264,000 | 354,000 |
Cash | 6,532,000 | 9,598,000 | 7,831,000 | 6,299,000 | 1,295,000 | 2,142,000 | 2,741,000 | 2,996,000 | 2,806,000 | 2,555,000 | 2,495,000 | 2,184,000 | 1,285,000 | 1,855,000 | 1,312,000 |
misc current assets | 533,000 | 507,000 | 509,000 | 504,000 | 500,000 | 500,000 | |||||||||
total current assets | 8,694,000 | 11,535,000 | 12,083,000 | 8,838,000 | 4,114,000 | 4,221,000 | 4,702,000 | 4,167,000 | 4,013,000 | 3,379,000 | 3,331,000 | 2,646,000 | 2,137,000 | 2,161,000 | 1,796,000 |
total assets | 22,204,000 | 21,228,000 | 19,966,000 | 16,916,000 | 12,531,000 | 12,362,000 | 13,013,000 | 12,604,000 | 12,627,000 | 12,189,000 | 11,490,000 | 9,707,000 | 9,416,000 | 9,492,000 | 9,164,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 379,000 | 265,000 | 271,000 | 224,000 | 165,000 | 175,000 | 245,000 | 217,000 | 205,000 | 154,000 | 348,000 | 128,000 | 115,000 | 272,000 | 134,000 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 682,000 | 886,000 | 824,000 | 736,000 | 361,000 | 420,000 | 384,000 | 334,000 | 476,000 | 416,000 | 570,000 | 512,000 | 567,000 | 504,000 | 647,000 |
total current liabilities | 1,061,000 | 1,151,000 | 1,095,000 | 960,000 | 526,000 | 595,000 | 629,000 | 551,000 | 681,000 | 570,000 | 918,000 | 640,000 | 682,000 | 776,000 | 781,000 |
loans | 2,000,000 | ||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | 2,000,000 | ||||||||||||||
total liabilities | 1,061,000 | 1,151,000 | 1,095,000 | 2,960,000 | 526,000 | 595,000 | 629,000 | 551,000 | 681,000 | 570,000 | 918,000 | 640,000 | 682,000 | 776,000 | 781,000 |
net assets | 21,143,000 | 20,077,000 | 18,871,000 | 13,956,000 | 12,005,000 | 11,767,000 | 12,384,000 | 12,053,000 | 11,946,000 | 11,619,000 | 10,572,000 | 9,067,000 | 8,734,000 | 8,716,000 | 8,383,000 |
total shareholders funds | 21,143,000 | 20,077,000 | 18,871,000 | 13,956,000 | 12,005,000 | 11,767,000 | 12,384,000 | 12,053,000 | 11,946,000 | 11,619,000 | 10,572,000 | 9,067,000 | 8,734,000 | 8,716,000 | 8,383,000 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 507,000 | 494,000 | 479,000 | 467,000 | 467,000 | 495,000 | 476,000 | 482,000 | 453,000 | 470,000 | 457,000 | 431,000 | 384,000 | 322,000 | |
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | 3,000 | 2,000 | -8,000 | 5,000 | 3,000 | 1,000 | 7,000 | -2,000 | 3,000 | 1,000 | -6,000 | 7,000 | -1,000 | 3,000 | |
Debtors | 196,000 | -2,824,000 | 1,721,000 | 224,000 | 732,000 | 113,000 | 283,000 | -34,000 | 380,000 | -12,000 | 373,000 | 116,000 | 39,000 | -177,000 | 481,000 |
Creditors | 114,000 | -6,000 | 47,000 | 59,000 | -10,000 | -70,000 | 28,000 | 12,000 | 51,000 | -194,000 | 220,000 | 13,000 | -157,000 | 138,000 | 134,000 |
Accruals and Deferred Income | -204,000 | 62,000 | 88,000 | 375,000 | -59,000 | 36,000 | 50,000 | -142,000 | 60,000 | -154,000 | 58,000 | -55,000 | 63,000 | -143,000 | 647,000 |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | -325,000 | -350,000 | -305,000 | -1,158,000 | -1,495,000 | -276,000 | -437,000 | -350,000 | -723,000 | ||||||
Change in Investments | 3,567,000 | 1,986,000 | -108,000 | -46,000 | 77,000 | -22,000 | -2,000 | 5,000 | 96,000 | ||||||
cash flow from investments | -3,567,000 | -1,986,000 | -325,000 | -350,000 | -305,000 | 108,000 | -1,112,000 | -1,572,000 | -254,000 | -435,000 | -355,000 | -819,000 | |||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -2,000,000 | 2,000,000 | |||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | 295,000 | -14,000 | -2,000,000 | 2,001,000 | 19,000 | 80,000 | 20,000 | -2,000 | 5,000 | 8,816,000 | |||||
cash and cash equivalents | |||||||||||||||
cash | -3,066,000 | 1,767,000 | 1,532,000 | 5,004,000 | -847,000 | -599,000 | -255,000 | 190,000 | 251,000 | 60,000 | 311,000 | 899,000 | -570,000 | 543,000 | 1,312,000 |
overdraft | |||||||||||||||
change in cash | -3,066,000 | 1,767,000 | 1,532,000 | 5,004,000 | -847,000 | -599,000 | -255,000 | 190,000 | 251,000 | 60,000 | 311,000 | 899,000 | -570,000 | 543,000 | 1,312,000 |
Perform a competitor analysis for keech hospice by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in LU3 area or any other competitors across 12 key performance metrics.
KEECH HOSPICE group structure
Keech Hospice has 1 subsidiary company.
Keech Hospice currently has 12 directors. The longest serving directors include Mr Peter Cannon (Jun 2018) and Mrs Miriam Heyes (Jan 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Peter Cannon | England | 66 years | Jun 2018 | - | Director |
Mrs Miriam Heyes | England | 44 years | Jan 2019 | - | Director |
Mr Jeffrey Lustig | England | 71 years | Mar 2020 | - | Director |
Mr Michael McMahon | England | 70 years | Mar 2020 | - | Director |
Mr Simon Ogden | England | 63 years | Mar 2021 | - | Director |
Mr Chandra Shekar | England | 55 years | Mar 2021 | - | Director |
Ms Debra Smith | England | 65 years | Oct 2023 | - | Director |
Mrs Judith Greevy | 69 years | Oct 2023 | - | Director | |
Mr Iain Malcolm | England | 62 years | Nov 2023 | - | Director |
Ms Rowena Craddock | England | 44 years | Mar 2025 | - | Director |
P&L
March 2024turnover
15.4m
+15%
operating profit
604.6k
0%
gross margin
38.5%
+1.94%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
21.1m
+0.05%
total assets
22.2m
+0.05%
cash
6.5m
-0.32%
net assets
Total assets minus all liabilities
company number
02904446
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
March 1994
age
31
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
March 2024
previous names
keech hospice care (March 2025)
pasque charity (September 2009)
See moreaccountant
-
auditor
HAYSMACINTYRE LLP
address
keech hospice care, great bramingham lane, luton, LU3 3NT
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
PICTONS LLP PINNEY TALFOURD LLP SA LAW VEALE WASBOROUGH VIZARDS LLP
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to keech hospice. Currently there are 1 open charges and 0 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KEECH HOSPICE. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|